1. Home
  2. STXS vs EARN Comparison

STXS vs EARN Comparison

Compare STXS & EARN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STXS
  • EARN
  • Stock Information
  • Founded
  • STXS 1990
  • EARN 2012
  • Country
  • STXS United States
  • EARN United States
  • Employees
  • STXS N/A
  • EARN N/A
  • Industry
  • STXS Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • EARN Real Estate Investment Trusts
  • Sector
  • STXS Health Care
  • EARN Real Estate
  • Exchange
  • STXS Nasdaq
  • EARN Nasdaq
  • Market Cap
  • STXS 151.3M
  • EARN 187.6M
  • IPO Year
  • STXS 2004
  • EARN 2013
  • Fundamental
  • Price
  • STXS $2.20
  • EARN $5.80
  • Analyst Decision
  • STXS
  • EARN Buy
  • Analyst Count
  • STXS 0
  • EARN 2
  • Target Price
  • STXS N/A
  • EARN $6.00
  • AVG Volume (30 Days)
  • STXS 288.7K
  • EARN 243.8K
  • Earning Date
  • STXS 08-11-2025
  • EARN 08-11-2025
  • Dividend Yield
  • STXS N/A
  • EARN 16.67%
  • EPS Growth
  • STXS N/A
  • EARN N/A
  • EPS
  • STXS N/A
  • EARN N/A
  • Revenue
  • STXS $27,510,000.00
  • EARN $35,893,000.00
  • Revenue This Year
  • STXS $25.90
  • EARN $3.21
  • Revenue Next Year
  • STXS $60.57
  • EARN $18.63
  • P/E Ratio
  • STXS N/A
  • EARN N/A
  • Revenue Growth
  • STXS 1.50
  • EARN 43.30
  • 52 Week Low
  • STXS $1.54
  • EARN $4.33
  • 52 Week High
  • STXS $2.72
  • EARN $7.20
  • Technical
  • Relative Strength Index (RSI)
  • STXS 52.17
  • EARN 55.89
  • Support Level
  • STXS $2.08
  • EARN $5.68
  • Resistance Level
  • STXS $2.36
  • EARN $5.79
  • Average True Range (ATR)
  • STXS 0.12
  • EARN 0.07
  • MACD
  • STXS -0.01
  • EARN -0.01
  • Stochastic Oscillator
  • STXS 55.56
  • EARN 71.43

About STXS Stereotaxis Inc.

Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.

About EARN Ellington Residential Mortgage REIT of Beneficial Interest

Ellington Credit Co is focused on corporate collateralized loan obligations (CLOs). It focuses on acquiring, investing in, and managing secondary CLO mezzanine debt and equity tranches. The company relies on strong risk management, including disciplined liquidity management and selective use of credit hedges, to preserve book value during times of stress. It also leverages Ellington's proprietary technology, analytics and risk management systems to enhance underwriting and investment selection and to guide ongoing portfolio monitoring and surveillance.

Share on Social Networks: